Extended-spectrum β-lactamases

Seminars in Respiratory Infections

Volumn 17, Issue 3, 2002, Pages 189-194

  Larson, Laura L ^a   Ramphal, Reuben ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL ENZYME; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; DRUG USE; ENTEROBACTER; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME SUBSTRATE COMPLEX; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL; HOSPITAL INFECTION; HUMAN; KLEBSIELLA; NURSING HOME; PATIENT CARE; PLASMID; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS; REVIEW; RISK FACTOR; SALMONELLA;

BACTERIAL INFECTIONS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; HUMANS;

EID: 0036733350     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2002.34687     Document Type: Review

References (35)

1. Hanson ND, Thompson KS, Moland ES, et al: Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC. J Antimicrob Chemother 44:377-380, 1999
2. Philippon A, Arlet G, Lagrange PH: Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 13:17-29, 1994 (suppl)
3. Schultz SC, Richards JH: Site-saturation studies of β-lactamase: Production and characterization of mutant β-lactamases with all possible amino acid substitutions at residue 71. Proc Natl Acad Sci U S A 83:1588-1592, 1986
4. Bush K: Characterization of β-lactamases. Antimicrob Agents Chemother 33:259-263, 1989
5. Philippon A, Labia R, Jacoby G: Extended-spectrum β-lactamases. Antimicrob Agents Chemother 33:1131-1136, 1989
6. Jacoby G: Amino acid sequences for TEM, SHV and OXA extended-spectrum beta-lactamases [on-line]. Accessed 2001. Available at: http://www.lahey.hitchcock.org/studies
7. Livermore D: Carbapenemases: The next generation of β-lactamases? ASM News 59:129-135, 1993
8. Ambler RP: The structure of β-lactamases. Philos Trans R Soc Lond B Biol Sci 289:321-331, 1980
9. Barthélémy M, Péduzzi J, Bernard H, et al: Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochem Biophys Acta 289:15-22, 1992
10. Jacoby GA, Medeiros AA: More extended-spectrum β-lactamases. Antimicrob Agents Chemother 35:1697-1704, 1991
11. Watanabe Y, Iyobe S, Inoue M, et al: Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 35:147-151, 1991
12. Cornaglia G, Mazzariol A, Lauretti L, et al: Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin Infect Dis 31:1119-1125, 2000
13. Bandoh K, Watanabe K, Muto Y, et al: Conjugal transfer of imipenem resistance in Bacteriodes fragilis. J Antibiot (Tokyo) 45:542-547, 1992
14. Jacoby GA: Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect Dis Clin North Am 11:875-887, 1997
15. Jacoby GA: The genetics of extended-spectrum beta-lactamases. Eur J Clin Microbiol Dis 13:2-11, 1994 (suppl)
16. Rice LB, Marshall SH, Carias LL, et al: Sequences of MGH-1, YOU-1 and YOU-2 extended-spectrum beta-lactamase genes. Antimicrob Agents Chemother 37:2760-2761, 1993
17. Bradford PA, Urban C, Mariano N, et al: Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41:563-569, 1997
18. Essack SY: Laboratory detection of extended-spectrum β-lactamases (ESBLs)-The need for a reliable, reproducible method. Diagn Microbiol Infect Dis 37:293-295, 2000
19. Wu SW, Dornsbusch K, Gorannson E, et al: Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime. J Antimicrob Chemother 28:389-397, 1991
20. Wu SW, Dornsbusch K, Norgren M, et al: Extended spectrum β-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family. J Antimicrob Chemother 30:3-16, 1992
21. Thompson KS, Sanders CC: Detection of extended-spectrum β-lactamases in members of the family Enterbacteriaceae, comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother 35:1877-1882, 1992
22. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Disk Susceptibility tests (ed 6). Approved standard M2-A6. Villanova, PA, National Committee for Clinical Laboratory Standards, 1997
23. Sanders CC, Barry AL, Washington JA, et al: Detection of the extended-spectrum β-lactamase producing members if the family Enterobacteriaceae with the Vitek ESBL test. Antimicrob Agents Chemother 34:2997-3001, 1996
24. Burwen DR, Banerjee SN, Gaynes RP, et al: Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J Infect Dis 170:1622-1625, 1994
25. Jones RN, Jenkins SG, Hoban DJ, et al: In vitro efficacy of six cephalosporins tested against Enterbacteriaceae at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998. Int J Antimicrob Agents 15:111-118, 2000
26. Itokazu GS, Quinn JP, Bell-Dixon C, et al: Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive are units: Evaluation of a national post-marketing surveillance program. Clin Infect Dis 23:779-784, 1996
27. Saurina, G, Quale JM, Manikal VM, et al: Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: Epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother 45:895-898, 2000
28. Meyer KS, Urban C, Eagan JA, et al: Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119:353-358, 1993
29. Sciappa DA, Hayden MK, Matishek MG, et al: Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case control and molecular epidemiologic investigation. J Infect Dis 174:529-536, 1996
30. Wendt C, Messer SA, Hollis RJ, et al: Recurrent gram-negative bacteremia: Incidence and clinical patterns. Clin Infect Dis 28:611-617, 1999
31. Lucet J-C, Decre D, Fichelle A, et al: Control of a prolonged outbreak of extended-spectrum β-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis 29:1411-1418, 1999
32. Pilroth L, Aubé H, Doise J-M, et al: Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: Are β-lactamase inhibitors of therapeutic value? Clin Infect Dis 27:76-80, 1998
33. Babini GS, Livermore DM: Antimicrobial resistance among Klebsiella spp. Collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother 45:183-189, 2000
34. Rebuck JA, Olsen KM, Fey PD, et al: In vitro activities of parenteral beta-lactam antimicrobials against TEM-10-, TEM-26- and SHV-5-derived extended-spectrum beta-lactamases expressed in an isogenic escherichia coli host. J Antimicrob Chemother 46:461-464, 2000
35. Jacoby GA, Suton L: Properties of plasmids responsible for extended beta-lactamase production. Antimicrob Agents Chemother 35:164-169, 1991